Trial reportFrontiers in psychiatry2026
Therapeutic potential of low-frequency transcranial magnetic stimulation in children with autism spectrum disorder: sensory and behavioral outcomes-a randomized trial.
Trial report in Frontiers in psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06524310 (Effects of Repetitive Transcranial Magnetic Stimulation), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Effects of Repetitive Transcranial Magnetic Stimulation (rTMS) on Cognitive Functions and Behavior in Individuals With Autism Spectrum Disorder ( ASD)
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Autism spectrum disorder (ASD) is a neurodevelopmental disorder that affects individuals across multiple life domains. Despite this, therapeutic options remain scarce, with none officially approved for its treatment. One recently explored treatment modality is repetitive transcranial magnetic stimulation (rTMS), a noninvasive neurostimulation intervention. This study examines the effectiveness of low-frequency rTMS in improving social, cognitive, and sensory function in individuals with ASD. Method: The study included 35 children aged 5 to 10 years who had been diagnosed with ASD. Participants were randomly assigned to two groups: 17 children received rTMS treatment twice weekly (active group), while the remaining 18 served as a waitlist (WTL) control group. Outcome measures were collected at baseline (preintervention) and 3 weeks after the completion of the 9-week rTMS intervention (postintervention). Results: Significant ( Conclusion: The findings of this study suggest that low-frequency rTMS may have potential as an adjunctive intervention for specific ASD-related symptoms in social, cognitive, and sensory domains. However, further research is warranted to validate and expand these preliminary observations. Clinical Trial Registration: https://clinicaltrials.gov/study/NCT06524310, identifier NCT06524310.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.